Ola Landgren - Concepedia

Author

Ola Landgren

Also Known As

C Landgren, C Ola Landgren, C. O. Landgren, C. Ola Landgren, C.O. Landgren, Carl Ola Landgren, Kmieciak, Maciej, Landgren O, Landgren, O, Martha Lacy

1.4K

Publications

42.8K

Citations

101

H-Index

188

Concepts

All Affiliations

National Cancer Institute Memorial Sloan Kettering Cancer Center National Institutes of Health Center for Cancer Research Karolinska University Hospital

About

Ola Landgren is an author at National Cancer Institute specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	94	10.6K
2	Health Sciences	21	30	6.7K
3	Public Health	19	22	1.6K
4	Engineering	4	4	376
5	Allergy	2	2	179

Ola Landgren

311

Publications

29.9K

Citations

H-Index

Page 1

	Year	Citations
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo, The Lancet Oncology Hematological MalignancyMedicineHematologyDiagnosisPathology	2014	4.7K
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study Ola Landgren, Robert A. Kyle, Ruth M. Pfeiffer, Blood	2009	1.1K
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos, Blood	2015	739
Solid cancers after allogeneic hematopoietic cell transplantation J. Douglas Rizzo, Rochelle E. Curtis, Gèrard Socié, Blood	2008	481
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study Meletios Α. Dimopoulos, Hang Quach, María‐Victoria Mateos, The Lancet Hematological MalignancyMedicineHematologyClinical TrialsVersus Carfilzomib	2020	415
Racial disparities in incidence and outcome in multiple myeloma: a population-based study Adam Waxman, Pamela J. Mink, Susan S. Devesa, Blood	2010	397
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation Ola Landgren, Ethel S. Gilbert, J. Douglas Rizzo, Blood	2009	396
GPRC5D-Targeted CAR T Cells for Myeloma Sham Mailankody, Sean M. Devlin, Jonathan Landa, New England Journal of Medicine	2022	367
B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia Ola Landgren, Maher Albitar, Wanlong Ma, New England Journal of Medicine	2009	362
Risk of Non-Hodgkin Lymphoma and Lymphoproliferative Precursor Diseases in US Veterans With Hepatitis C Virus Thomas P. Giordano, Louise M. Henderson, Ola Landgren, JAMA	2007	331

Page 1